We are live on
!
Find out more
AAM
AR Asset Management Portfolio holdings
AUM
$546M
1-Year Est. Return
24.08%
This Fund
S&P 500
This Quarter
Est. Return
+11.81%
1 Year Est. Return
+24.08%
3 Year Est. Return
+64.88%
5 Year Est. Return
+92.85%
10 Year Est. Return
+1,439.33%
AUM
$394M
AUM Growth
+$36.8M
(+10%)
Cap. Flow
-$1.71M
Cap. Flow
% of AUM
-0.43%
Top 10 Holdings %
Top 10 Hldgs %
39.41%
Holding
121
New
2
Increased
3
Reduced
11
Closed
5
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Organon & Co
OGN
|
+$2.84M |
| 2 |
RXDX
Prometheus Biosciences, Inc. Common Stock
RXDX
|
+$872K |
| 3 |
Church & Dwight Co
CHD
|
+$218K |
| 4 |
Amazon
AMZN
|
+$3.42K |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.66K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AT&T
T
|
+$1.97M |
| 2 |
Verizon
VZ
|
+$1.73M |
| 3 |
Marker Therapeutics
MRKR
|
+$276K |
| 4 |
VMEO
Vimeo
VMEO
|
+$235K |
| 5 |
Viatris
VTRS
|
+$233K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Staples | 22.72% |
| 2 | Technology | 17.29% |
| 3 | Healthcare | 13.63% |
| 4 | Financials | 12.11% |
| 5 | Consumer Discretionary | 8.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Yum China
YUMC
$16.2B
| $292K | 0.07% |
5,853
| – | – |
|
|
HLTH
102
DELISTED
Cue Health Inc. Common Stock
HLTH
| $268K | 0.07% |
20,000
| – | – |
|
103
Agilent Technologies
A
$42B
| $266K | 0.07% |
1,669
| – | – |
|
|
BKI
104
DELISTED
Black Knight, Inc. Common Stock
BKI
| $266K | 0.07% |
3,206
| – | – |
|
105
Oracle
ORCL
$442B
| $262K | 0.07% |
3,000
| – | – |
|
106
COPT Defense Properties
CDP
$4.23B
| $255K | 0.06% |
9,100
| – | – |
|
107
MetLife
MET
$62.1B
| $250K | 0.06% |
4,000
| – | – |
|
|
108
Church & Dwight Co
CHD
$23.9B
| $246K | 0.06% |
+2,400
| New | +$218K |
|
109
Allstate
ALL
$65.6B
| $235K | 0.06% |
2,000
| – | – |
|
110
Aegon
AEG
$14B
| $181K | 0.05% |
38,364
| – | – |
|
|
111
Marker Therapeutics
MRKR
$19.2M
| $68K | 0.02% |
7,150
-20,750
| -74% | -$276K |
|
|
112
AT&T
T
$170B
| – | – |
-96,663
| Closed | -$1.97M |
|
|
VMEO
113
DELISTED
Vimeo
VMEO
| – | – |
-7,989
| Closed | -$235K |
|
|
114
Viatris
VTRS
$18.5B
| – | – |
-17,164
| Closed | -$233K |
|
|
CS
115
DELISTED
Credit Suisse Group
CS
| – | – |
-10,000
| Closed | -$99K |
|
Similar funds
AA
HIS
BCM
WCP
FMC
SVCM
CM
CAM
AR Asset Management's Q4 2021 Portfolio in Review
As of Q4 2021, AR Asset Management held 121 positions worth $394M, up 10% from $357M the previous quarter. Its ten largest holdings account for 39% of the portfolio.
AR Asset Management's Q4 2021 filing shows 2 new, 3 increased, 11 reduced and 5 closed positions. Its largest new stake was Prometheus Biosciences, Inc. Common Stock: 27,857 shares worth $1.1M. The largest sale was AT&T, an estimated $1.97M.
By sector, the portfolio is most concentrated in Consumer Staples at 23% of assets, down from 23% a quarter earlier, followed by Technology and Healthcare.
- AR Asset Management's largest Q4 2021 buy was Prometheus Biosciences, Inc. Common Stock: 27,857 shares worth $1.1M.
- AR Asset Management added most to Organon & Co in Q4 2021, an estimated $2.84M increase.
- AR Asset Management's biggest Q4 2021 reduction was Verizon, cutting an estimated $1.73M.
- AR Asset Management fully exited AT&T in Q4 2021, selling an estimated $1.97M.
- AR Asset Management's ten largest holdings make up 39% of its $394M portfolio in Q4 2021.
- AR Asset Management opened 2 new positions and closed 5 in Q4 2021.
- AR Asset Management's portfolio value rose 10% quarter-over-quarter to $394M.
Based on AR Asset Management's 13F filing for Q4 2021, filed 7 Feb 2022.